Literature DB >> 14986080

Attempted treatment of factor H deficiency by liver transplantation.

Hae Il Cheong1, Byong Sop Lee, Hee-Gyung Kang, Hyewon Hahn, Kyung-Suk Suh, Il Soo Ha, Yong Choi.   

Abstract

Complement factor H (FH) deficiency is one of the causes of atypical hemolytic uremic syndrome (HUS). Most patients with FH deficiency associated HUS progress to end-stage renal disease despite plasma therapy. Moreover, the disease invariably recurs in the graft kidney and causes graft failure. We confirmed FH deficiency in a 30-month-old boy with recurrent HUS of 2 years duration, and attempted an auxiliary partial orthotopic liver transplantation (APOLT) to overcome the sustained intractable dependency on plasma therapy. APOLT restored the plasma FH level, without HUS recurrence, for 7 months. However, thereafter he suffered from serious infectious complications associated with immunosuppression and finally died 11 months after APOLT. In conclusion, although APOLT showed clinical and laboratory improvement for some period in this patient, the final fatal outcome suggests that liver transplantation should be cautiously applied to patients with HUS associated with FH deficiency.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14986080     DOI: 10.1007/s00467-003-1371-2

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Combined kidney and liver transplantation for familial haemolytic uraemic syndrome.

Authors:  Giuseppe Remuzzi; Piero Ruggenenti; Daniela Codazzi; Marina Noris; Jessica Caprioli; Giuseppe Locatelli; Bruno Gridelli
Journal:  Lancet       Date:  2002-05-11       Impact factor: 79.321

2.  Genetic studies into inherited and sporadic hemolytic uremic syndrome.

Authors:  P Warwicker; T H Goodship; R L Donne; Y Pirson; A Nicholls; R M Ward; P Turnpenny; J A Goodship
Journal:  Kidney Int       Date:  1998-04       Impact factor: 10.612

3.  The molecular basis of familial hemolytic uremic syndrome: mutation analysis of factor H gene reveals a hot spot in short consensus repeat 20.

Authors:  Jessica Caprioli; Paola Bettinaglio; Peter F Zipfel; Barbara Amadei; Erica Daina; Sara Gamba; Christine Skerka; Nicola Marziliano; Giuseppe Remuzzi; Marina Noris
Journal:  J Am Soc Nephrol       Date:  2001-02       Impact factor: 10.121

4.  Familial hemolytic uremic syndrome associated with complement factor H deficiency.

Authors:  D Landau; H Shalev; G Levy-Finer; A Polonsky; Y Segev; L Katchko
Journal:  J Pediatr       Date:  2001-03       Impact factor: 4.406

5.  Complement factor H gene mutation associated with autosomal recessive atypical hemolytic uremic syndrome.

Authors:  L Ying; Y Katz; M Schlesinger; R Carmi; H Shalev; N Haider; G Beck; V C Sheffield; D Landau
Journal:  Am J Hum Genet       Date:  1999-12       Impact factor: 11.025

Review 6.  Complement factor H and hemolytic uremic syndrome.

Authors:  P F Zipfel; C Skerka; J Caprioli; T Manuelian; H H Neumann; M Noris; G Remuzzi
Journal:  Int Immunopharmacol       Date:  2001-03       Impact factor: 4.932

7.  Atypical (non-diarrhea-associated) hemolytic-uremic syndrome in childhood.

Authors:  M M Fitzpatrick; M D Walters; R S Trompeter; M J Dillon; T M Barratt
Journal:  J Pediatr       Date:  1993-04       Impact factor: 4.406

8.  Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H.

Authors:  Matthew C Pickering; H Terence Cook; Joanna Warren; Anne E Bygrave; Jill Moss; Mark J Walport; Marina Botto
Journal:  Nat Genet       Date:  2002-07-01       Impact factor: 38.330

9.  Control of the amplification convertase of complement by the plasma protein beta1H.

Authors:  J M Weiler; M R Daha; K F Austen; D T Fearon
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205

10.  Human complement factor H: two factor H proteins are derived from alternatively spliced transcripts.

Authors:  C Estaller; W Schwaeble; M Dierich; E H Weiss
Journal:  Eur J Immunol       Date:  1991-03       Impact factor: 5.532

View more
  19 in total

Review 1.  The role of complement in the early immune response to transplantation.

Authors:  Steven H Sacks; Wuding Zhou
Journal:  Nat Rev Immunol       Date:  2012-05-25       Impact factor: 53.106

2.  A case of atypical hemolytic uremic syndrome with a transient decrease in complement factor H.

Authors:  Hyewon Hahn; Eun Young Um; Young Seo Park; Hae Il Cheong
Journal:  Pediatr Nephrol       Date:  2005-12-17       Impact factor: 3.714

Review 3.  What's new in haemolytic uraemic syndrome?

Authors:  Sally Johnson; C Mark Taylor
Journal:  Eur J Pediatr       Date:  2008-06-25       Impact factor: 3.183

Review 4.  Guidelines for the management and investigation of hemolytic uremic syndrome.

Authors:  Takashi Igarashi; Shuichi Ito; Mayumi Sako; Akihiko Saitoh; Hiroshi Hataya; Masashi Mizuguchi; Tsuneo Morishima; Kenji Ohnishi; Naohisa Kawamura; Hirotsugu Kitayama; Akira Ashida; Shinya Kaname; Hiromichi Taneichi; Julian Tang; Makoto Ohnishi
Journal:  Clin Exp Nephrol       Date:  2014-08       Impact factor: 2.801

Review 5.  Renal transplantation in HUS patients with disorders of complement regulation.

Authors:  Lothar Bernd Zimmerhackl; Johanna Scheiring; Friederike Prüfer; C Mark Taylor; Chantal Loirat
Journal:  Pediatr Nephrol       Date:  2006-10-21       Impact factor: 3.714

Review 6.  New insights into postrenal transplant hemolytic uremic syndrome.

Authors:  Julien Zuber; Moglie Le Quintrec; Rebecca Sberro-Soussan; Chantal Loirat; Véronique Frémeaux-Bacchi; Christophe Legendre
Journal:  Nat Rev Nephrol       Date:  2010-11-23       Impact factor: 28.314

7.  Liver-kidney transplantation to cure atypical HUS: still an option post-eculizumab?

Authors:  Jeffrey Saland
Journal:  Pediatr Nephrol       Date:  2013-12-22       Impact factor: 3.714

8.  Efficacy of plasma therapy in atypical hemolytic uremic syndrome with complement factor H mutations.

Authors:  Anne-Laure Lapeyraque; Eric Wagner; Véronique Phan; Marie-José Clermont; Aïcha Merouani; Véronique Frémeaux-Bacchi; Timothy H J Goodship; Pierre Robitaille
Journal:  Pediatr Nephrol       Date:  2008-04-19       Impact factor: 3.714

9.  Severe atypical HUS caused by CFH S1191L--case presentation and review of treatment options.

Authors:  Sudarsana De; Aoife M Waters; Audrey O Segal; Agnes Trautmann; Elizabeth A Harvey; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2009-10-24       Impact factor: 3.714

10.  Anesthetic management of living donor liver transplantation for complement factor H deficiency hemolytic uremic syndrome: a case report.

Authors:  Suk-Hee Park; Gaab-Soo Kim
Journal:  Korean J Anesthesiol       Date:  2014-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.